A COMPARATIVE OBSERVATIONAL STUDY OF ROPIVACAINE WITH DEXAMETHASONE VERSUS ROPIVACAINE WITH BUPRENORPHINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Background: Supraclavicular brachial plexus block is a widely used regional anesthetic technique for upper limb surgeries, offering excellent intraoperative and postoperative analgesia. However,the duration of analgesia from local anesthetics like ropivacaine is often limited,prompting the use of adjuvants to enhance and prolong the block's efficacy. Among the commonly used adjuvants, dexamethasone and buprenorphine have gained popularity due to their effectiveness in enhancing analgesia without significant complications.Aim: This study aimed to compare the onset, duration, and efficacy of supraclavicular brachial plexus block using ropivacaine with dexamethasone (RD) versus ropivacaine with buprenorphine (RB) in patients undergoing upper limb surgeries.Methods:A prospective observational study was conducted on 60 patients aged 20–45 years,classified as ASA I–III,and posted for elective upper limb orthopaedic procedures.Patients were randomly assigned into two equal groups:Group RD received 30 ml of 0.5% ropivacaine with 4 mg dexamethasone,and Group RB received 30 ml of 0.5% ropivacaine with 3 mcg/kg buprenorphine. Parameters assessed included the onset and duration of sensory and motor block, time to first rescue analgesia, and hemodynamic stability.Results: Group RD showed a significantly prolonged duration of sensory block (19.68 ± 2.53 hrs vs.12.25 ± 2.53 hrs),motor block (14.81 ± 2.24 hrs vs.9.06 ± 1.97 hrs),and delayed time to first rescue analgesia (21.78 ± 2.08 hrs vs.14.73 ± 1.81 hrs) compared to Group RB (p < 0.001).Hemodynamic parameters and incidence of side effects were comparable between groups.Conclusion: The addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block resulted in significantly longer sensory and motor blockade and delayed need for rescue analgesia compared to buprenorphine,indicating that dexamethasone may be a more effective adjuvant in prolonging postoperative analgesia.This study supports the use of ropivacaine with dexamethasone as a preferred combination for supraclavicular brachial plexus block in upper limb surgeries.

Authors

Institutions

Publication Details

Journal
PARIPEX INDIAN JOURNAL OF RESEARCH
Published
2025-08-15
DOI
https://doi.org/10.36106/paripex/7508760
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A COMPARATIVE OBSERVATIONAL STUDY OF ROPIVACAINE WITH DEXAMETHASONE VERSUS ROPIVACAINE WITH BUPRENORPHINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Geetha Soundarya, Yasmin Mariam S. G, NithinAbraham Raju
PARIPEX INDIAN JOURNAL OF RESEARCH
Anesthesia and Pain Management
article

A COMPARATIVE OBSERVATIONAL STUDY OF ROPIVACAINE WITH DEXAMETHASONE VERSUS ROPIVACAINE WITH BUPRENORPHINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Geetha Soundarya, Yasmin Mariam S. G, NithinAbraham Raju
article en

Abstract

Background: Supraclavicular brachial plexus block is a widely used regional anesthetic technique for upper limb surgeries, offering excellent intraoperative and postoperative analgesia. However,the duration of analgesia from local anesthetics like ropivacaine is often limited,prompting the use of adjuvants to enhance and prolong the block's efficacy. Among the commonly used adjuvants, dexamethasone and buprenorphine have gained popularity due to their effectiveness in enhancing analgesia without significant complications.Aim: This study aimed to compare the onset, duration, and efficacy of supraclavicular brachial plexus block using ropivacaine with dexamethasone (RD) versus ropivacaine with buprenorphine (RB) in patients undergoing upper limb surgeries.Methods:A prospective observational study was conducted on 60 patients aged 20–45 years,classified as ASA I–III,and posted for elective upper limb orthopaedic procedures.Patients were randomly assigned into two equal groups:Group RD received 30 ml of 0.5% ropivacaine with 4 mg dexamethasone,and Group RB received 30 ml of 0.5% ropivacaine with 3 mcg/kg buprenorphine. Parameters assessed included the onset and duration of sensory and motor block, time to first rescue analgesia, and hemodynamic stability.Results: Group RD showed a significantly prolonged duration of sensory block (19.68 ± 2.53 hrs vs.12.25 ± 2.53 hrs),motor block (14.81 ± 2.24 hrs vs.9.06 ± 1.97 hrs),and delayed time to first rescue analgesia (21.78 ± 2.08 hrs vs.14.73 ± 1.81 hrs) compared to Group RB (p < 0.001).Hemodynamic parameters and incidence of side effects were comparable between groups.Conclusion: The addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block resulted in significantly longer sensory and motor blockade and delayed need for rescue analgesia compared to buprenorphine,indicating that dexamethasone may be a more effective adjuvant in prolonging postoperative analgesia.This study supports the use of ropivacaine with dexamethasone as a preferred combination for supraclavicular brachial plexus block in upper limb surgeries.

PARIPEX INDIAN JOURNAL OF RESEARCH
Sree Balaji Dental College and Hospital (IN)
Openalex Percentile: Top 61%
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.